جست‌وجوی استاد و پژوهشگر

• Radiation Oncology
• Medical Physics
• Treatment Planning Techniques
• +۵ مورد دیگر

Dr. Sotirios Stathakis is Chief of Physics at the Mary Bird Perkins Cancer Center (2023–Present) and Associate Director of the Medical Physics Division at the University of Texas Health Science Center San Antonio (2017–2022). He holds an Adjunct Professor position at Louisiana State University's Department of Physics and Astronomy (2023–Present). His expertise lies in radiation oncology and medical physics, with a focus on patient-specific quality assurance, dose verification, and advanced treatment techniques like adaptive radiation therapy and SBRT. Education: Ph.D., Medical Physics, University of Patras (2005) M.S., Medical Physics, University of Aberdeen (1997) B.S., Physics (minor in Mathematics and Computer Science), University of Waterloo (1995) Research Interests: Patient-specific quality assurance Daily dose verification Treatment planning techniques Adaptive radiation therapy Stereotactic body radiation therapy (SBRT) Automation and workflow optimization in radiation oncology Publications: Over 20 peer-reviewed articles since 2020, focusing on topics like Monte Carlo simulations, AI-driven beam analysis, and AAPM task group recommendations for IMRT verification. Key themes include improving dose accuracy, equipment validation, and clinical implementation of advanced radiation technologies. Grants & Awards: Not explicitly listed in provided text. Labs/Teams: Collaborates with institutions like Fox Chase Cancer Center, South Texas Veterans Health Administration, and LSU on medical physics research and clinical applications.

• Medical Physics
• Radiation Oncology
• Therapeutic Radiology
• +۷ مورد دیگر

Huixiao Chen is an Assistant Professor and Clinical Medical Physicist II in the Department of Therapeutic Radiology at Yale School of Medicine. She holds a primary appointment in Therapeutic Radiology and is actively engaged in clinical and research activities related to radiation oncology physics. Assistant Professor, Department of Therapeutic Radiology, Yale School of Medicine Clinical Medical Physicist II, Therapeutic Radiology Education: Resident, Yale University (2016) Postdoctoral Fellow, Harvard University (2013) Postdoctoral Fellow, Virginia Commonwealth University (2011) PhD, University of Heidelberg, Germany (2010) MS, Zhejiang University, China (1998) BS, Zhejiang University, China (1995) Huixiao Chen's research centers on medical physics in radiation oncology, with a focus on treatment planning optimization, dosimetry, and image-guided radiotherapy. Her work includes the development and evaluation of advanced radiotherapy techniques such as VMAT and SBRT, with applications in spine, lung, and prostate cancers. She has contributed to improving the accuracy of dose calculations using Monte Carlo methods and has explored the impact of patient motion on treatment delivery. Her research also extends to the design of clinical devices to support safe and effective radiotherapy for diverse patient populations. Her recent publications demonstrate a consistent focus on enhancing the precision and efficiency of radiotherapy. Key themes include multicriteria optimization in treatment planning, dosimetric validation of radiochromic films, and the development of supportive devices for image-guided radiotherapy. These works reflect a strong commitment to advancing clinical medical physics through both computational and engineering innovations. Scientific Contributions: Characterization of GafchromicTM EBT4 film for clinical dosimetry Design of a small-footprint couch-top support for heavy patients in IGRT Application of multicriteria optimization in VMAT planning for spine and prostate cancers Comparison of Monte Carlo vs. pencil beam algorithms in lung SBRT Analysis of diaphragm motion effects on spine SBRT Huixiao Chen has collaborated with researchers such as Emily Draeger and Zhe Jay Chen on various projects. While no formal students or grants are listed, her role as a clinical medical physicist and faculty member suggests active mentorship and potential involvement in funded research. She is a key contributor to the medical physics team at Yale, ensuring high standards in treatment planning and delivery.

Christian Rønn Hansenمشاهده پروفایل

دانشیار

• Radiation Therapy
• Head and Neck Cancer
• Treatment Planning
• +۷ مورد دیگر

Christian Rønn Hansen is an Associate Professor at the Department of Clinical Research, University of Southern Denmark , specializing in radiation therapy and oncology. His work spans head and neck cancer, prostate cancer, and glioma treatment planning, with a focus on advanced radiation techniques like VMAT, IMRT, and hypofractionation. Academic Affiliation : Department of Clinical Research, University of Southern Denmark Research Collaborations : KI (Karolinska Institute), OUH (Odense University Hospital), Danish Head and Neck Cancer Group (DAHANCA) Research Interests : Christian's research integrates artificial intelligence with magnetic resonance imaging for treatment adaptation, clinical trial quality assurance for radiation therapy, and pattern of failure analysis in head and neck cancer. His work also addresses thromboembolic risk in glioma patients and proton therapy applications for grade 1–3 gliomas. Scientific Contributions : His recent publications include systematic reviews on loco-regional failure patterns in head and neck cancer (2025), national data solutions for radiation oncology (2025), and AI-driven prostate volume analysis in hypo-fractionated radiotherapy (2025). He contributed to the 2023 ACTA ONCOLOGICA AWARD-winning work and leads discussions on international radiotherapy quality assurance standards. Scientific Awards : ACTA ONCOLOGICA AWARD (2023)

• Radiation Therapy
• Medical Physics
• Oncology
• +۳ مورد دیگر

Ping Xia, PhD, is a Physician Scientist affiliated with Cleveland Clinic's Department of Radiation Oncology. She holds primary appointments at the Cleveland Clinic Main Campus and specializes in advanced radiation therapy techniques. Her expertise includes image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT), focusing on precision oncology treatments. Dr. Xia received her undergraduate and graduate degrees in Physics from Beijing Normal University (1983, 1986) and completed her medical physics education at the University of Virginia (1993). She has been actively involved in clinical research, particularly in optimizing radiation therapy protocols to improve patient outcomes. Her current roles emphasize translational research and clinical applications of advanced radiation technologies. No industry financial relationships were reported as of April 2024.

• Radiation Oncology
• Therapeutic Radiology
• Cancer Treatment
• +۸ مورد دیگر

Dr. Patrick Oh serves as an Assistant Professor of Therapeutic Radiology at Yale School of Medicine, practicing as a radiation oncologist at Yale Cancer Center and Smilow Cancer Hospital. He specializes in treating thoracic and genitourinary cancers, as well as hematologic, cutaneous, and metastatic malignancies with an emphasis on individualized, holistic patient care to optimize both disease outcomes and quality of life. His educational background includes: BS from Duke University MD from Stony Brook University School of Medicine Preliminary Medicine Intern at NYU Langone Hospital-Long Island Resident Physician in Radiation Oncology at Yale New Haven Hospital (served as Chief Resident) Gamma Knife Cranial Radiosurgery Certification from Cleveland Clinic Dr. Oh's research focuses on reducing radiation-induced toxicities, particularly cardiopulmonary effects, and expanding the role of radiation therapy across various cancer types. His clinical expertise encompasses advanced radiotherapy techniques including stereotactic body radiation therapy (SBRT), intensity-modulated radiation therapy (IMRT/VMAT), and image-guided radiation therapy (IGRT). Professional recognition includes: RSNA Roentgen Resident Research Award (awarded June 7, 2025) Dr. Oh is dedicated to medical education, actively mentoring residents and medical students with emphasis on communication skills and patient-centered care. He maintains active professional memberships including the American Society for Therapeutic Radiology (2021-present), where he serves on the Board of the Korean American Society for Therapeutic Radiation Oncology (2024-present), and the American Society of Clinical Oncology (2018-present). He treats both adult and pediatric patients and accepts new appointments through Yale Medicine.

• Nonlinear Programming
• Optimization Methods
• Radiation Therapy Optimization
• +۲ مورد دیگر

Anders Forsgren is a Professor of Optimization and Systems Theory at the Department of Mathematics, KTH Royal Institute of Technology since 2003. His research focuses on nonlinear programming, particularly Newton-type methods for smooth optimization, with applications in radiation therapy, cell biology, and telecommunications. PhD in Optimization and Systems Theory (KTH, 1990) MS in Operations Research (Stanford, 1987) MSc in Engineering Physics (KTH, 1985) Research Interests: Anders develops methods for constrained optimization and applies them to intensity-modulated radiation therapy, metabolic networks, and wireless communication systems. His work bridges algorithmic innovation with real-world clinical and engineering challenges. Recent Publications: Focus on robust optimization for radiation therapy under uncertainty, quasi-Newton methods, and applications in medical physics. His 2025 papers address interplay-robust optimization and scenario positioning in proton therapy. Scientific Leadership: Co-chair, 8th SIAM Conference on Optimization (2005) Editorial board member, Computational Optimization and Applications (since 1998) Member, Mathematical Optimization Society and SIAM Mentorship: Supervises PhD students in optimization and systems theory, with former advisees working on radiation therapy robustness, metabolic modeling, and network design.

Sameer Nathمشاهده پروفایل

دانشیار

• Radiation Oncology
• Prostate Cancer
• Lung Cancer
• +۳ مورد دیگر

Sameer Nath, MD, is an Associate Professor in the Department of Radiation Oncology at the University of Colorado Anschutz Medical Campus School of Medicine. He holds leadership roles as Vice Chair of Clinical Affairs, Clinical Practice Director at Anschutz Medical Campus, and Medical Director of Radiation Oncology at Highlands Ranch Hospital. Dr. Nath is board-certified in Radiation Oncology and practices at UCHealth Radiation Oncology and Rocky Mountain Gamma Knife Center. MD: University of California, San Diego School of Medicine (2010) Internship: University of California, San Diego (2011) Residency: Yale-New Haven Medical Center, Chief Resident in Radiation Oncology (2015) His research focuses on radiation therapy applications for prostate and lung cancers, brain metastases management, and immunotherapy-radiation combinations. He has pioneered work in stereotactic body radiation therapy (SBRT), tumor hypoxia, radiation pneumonitis prevention, and medical imaging innovations for treatment planning. Recent publications examine oligoprogressive prostate cancer management, radiation oncology nurse education, and deep learning applications in patient positioning. Dr. Nath's 15 most recent publications (2024-2017) demonstrate expertise in prostate cancer (4 articles), lung cancer (4 articles), brain metastases (4 articles), and medical imaging/education (3 articles). Key research themes include SBRT optimization, immunotherapy response monitoring, and radiation toxicity management. American Society of Radiation Oncology (ASTRO) Member Practice locations: UCHealth Radiation Oncology - Anschutz Medical Campus (Aurora, CO) and Rocky Mountain Gamma Knife Center - Anschutz Medical Campus (Aurora, CO) Hospital affiliations: UCHealth Highlands Ranch Hospital and University of Colorado Hospital

• Head and Neck Cancer
• Prostate Cancer
• Radiation Oncology
• +۸ مورد دیگر

Dr. Julie Kang, MD, PhD is an Assistant Professor of Therapeutic Radiology at Yale School of Medicine and a board-certified radiation oncologist specializing in head and neck, prostate, bladder, and skin cancers. She practices at Smilow Cancer Hospital Care Center at Trumbull and is affiliated with Yale Cancer Center and Yale Medicine. Her educational background includes a BS from Yale University (2002), PhD from University of Southern California (2008), MD from University of Southern California (2010), and residency at UCLA (2015). Dr. Kang's research focuses on optimizing cancer treatment outcomes while minimizing toxicity through advanced radiation techniques including intensity-modulated radiation therapy, image-guided radiation therapy, stereotactic body radiation therapy, and adaptive radiation therapy. She has extensive experience conducting clinical trials utilizing immunotherapy and personalized medicine approaches for head and neck and prostate cancers. Her work emphasizes analyzing factors that influence cancer outcomes to enhance healthcare quality, with particular interest in addressing cancer disparities and reducing barriers to care. Analysis of Dr. Kang's recent publications (2022-2025) reveals a strong focus on treatment de-escalation strategies for HPV-associated oropharyngeal cancer, radiation dosing optimization for head and neck malignancies, and innovative applications of artificial intelligence in cancer care. Her research spans clinical trials, retrospective analyses, and systematic reviews addressing critical questions in radiation oncology with emphasis on improving patient outcomes while reducing treatment-related toxicity. Kaiser Permanente Everyday Hero Award Recipient (July 7, 2017) Kaiser Permanente Physician Merit Award (July 11, 2016) Dr. Kang is actively involved in clinical trials and cooperative groups, with a focus on mentoring the next generation of medical professionals in research related to head and neck and prostate cancers. Her clinical approach is deeply informed by personal experience as "the daughter of a cancer patient," emphasizing compassion, patient education, and personalized treatment planning. She is dedicated to not only delivering the highest standards of care but also raising them through continuous research and innovation in radiation oncology. As part of Yale's Therapeutic Radiology department, Dr. Kang contributes to a comprehensive cancer care program that includes state-of-the-art facilities such as the Yale Gamma Knife Center and Smilow Cancer Hospital, working within multidisciplinary teams to provide integrated cancer care across multiple locations including Hamden, Greenwich, and Lawrence and Memorial Cancer Center.

Peter B. Schiffمشاهده پروفایل

استاد

• Radiation Oncology
• Stereotactic Body Radiotherapy (SBRT)
• Immunotherapy
• +۴ مورد دیگر

Peter B. Schiff, MD, PhD is a Professor and Vice Chair in the Department of Radiation Oncology at NYU Grossman School of Medicine since 2009. He specializes in radiation oncology for lung, gynecologic, and other malignancies, emphasizing precision treatments like SBRT and IMRT. His clinical expertise includes non-small cell lung carcinoma, cervical/uterine cancers, and prostate cancer risk categorization. Education: MD from Albert Einstein College of Medicine (1984) PhD from Albert Einstein College of Medicine (1980) Residency in Radiation Oncology at Memorial Sloan-Kettering Cancer Center (1988) Research Interests: Focuses on stereotactic body radiotherapy (SBRT) for lung cancer, immunotherapy-radiation combinations, and IMRT/chemotherapy for gynecologic cancers. Active in clinical trials for prostate cancer treatment optimization and radiation dosimetry standards. Awards: Castle Connolly Top Doctor designation for over 15 years Clinical Trials: Leads trials on prostate cancer de-intensification strategies, novel therapies like MOMA-313, and perirectal spacing hydrogel systems in prostate radiotherapy.

Isabella Fornacon-Woodمشاهده پروفایل

پژوهشگر

• Radiation Therapy
• Lung Cancer
• Radiomics
• +۳ مورد دیگر

Isabella Fornacon-Wood is a Researcher at The University of Manchester's Division of Cancer Sciences, based at The Christie Hospital. She focuses on applying statistical methods to real-world patient data to improve cancer outcomes, particularly for under-represented groups. Her expertise includes radiomics, radiation therapy optimization, and pandemic impact analysis. Education: PhD in Cancer Sciences, The University of Manchester (2018–2023) MRes in Translational Medicine, The University of Manchester (2017–2018) BSc in Physics, Universitat Leipzig (2014–2017) Research Interests: Lung cancer treatment optimization via radiomics and real-world data Statistical analysis of radiation therapy outcomes Impact of pandemics on oncology care delivery Her recent work includes developing CT-based radiomic guidelines, analyzing patient-reported outcomes in oncology, and evaluating UK radiotherapy adaptations during the pandemic. Grants & Collaboration: Collaborations with institutions across the UK and international oncology networks Supervised by Prof. Faivre-Finn and Dr. Price in her PhD on real-world data applications Lab Affiliations: Radiotherapy Related Research Group at The Christie Hospital.

S. Murty Godduمشاهده پروفایل

استاد

• Radiation Oncology
• Medical Physics
• Quality Assurance (QA)
• +۶ مورد دیگر

S. Murty Goddu, PhD is a Professor of Radiation Oncology at Washington University School of Medicine. He earned his BS, MS, and PhD in Physics and Nuclear Physics from Andhra University, India, and completed a residency in medical physics at Washington University. His work focuses on quality assurance (QA) for radiation therapy systems, including linear accelerators, helical tomotherapy, and proton therapy. He has contributed to developing QA tools for 3D-conformal therapy, IMRT, Gamma-Knife, brachytherapy, and radiopharmaceutical treatments. Education: BS, Physics: Andhra University (1983) MS, Nuclear Physics: Andhra University (1985) PhD, Nuclear Physics: Andhra University (1991) Residency, Medical Physics: Washington University School of Medicine (1999) Certifications: American Board of Radiology, Therapeutic Medical Physics (2001) His research emphasizes improving patient safety through QA innovations, such as automated commissioning of radiotherapy systems, electronic chart checks, and deformable image registration. He has published extensively on topics like CBCT volumetric coverage extension , metal artifact reduction , and monitor unit calculations . Selected publications highlight advancements in: Proton therapy commissioning Helical tomotherapy QA Y-90 microsphere delivery protocols Bone marrow radiotoxicity studies Deformable image registration software (DIRART) Multimodality image registration He has collaborated with institutions on clinical trials and protocols for adaptive radiotherapy, dose calculation validation, and patient-specific QA. His work bridges physics, engineering, and clinical oncology to enhance treatment accuracy and safety.

• Radiation Oncology
• Translational Research
• Clinical Trials
• +۳ مورد دیگر

Kristine E. Kokeny, MD is an Associate Professor in the Department of Radiation Oncology at the University of Utah and a physician at Huntsman Cancer Institute , where she contributes to multidisciplinary teams for breast , lung , and genitourinary cancer care. Clinical Expertise: Radiation therapy for breast, lung, and genitourinary malignancies. Research Focus: Translational research and clinical trials evaluating novel therapies to enhance treatment outcomes and survival. Her recent publications emphasize radiation therapy techniques (e.g., IMRT, SBRT), cancer-specific outcomes , and health disparities . Dr. Kokeny is certified by the American Board of Radiology and is a member of prominent oncology societies, including ASTRO and ASCO .

Marilyn N. Lingمشاهده پروفایل

دانشیار

• Radiation Oncology
• Breast Cancer
• Radiation Treatment Modalities
• +۳ مورد دیگر

Marilyn N. Ling, M.D., is an Associate Professor of Radiation Oncology at the University of Rochester Medical Center's School of Medicine and Dentistry. She is actively involved in clinical practice and research, focusing on breast cancer treatment and radiation therapy innovations. Board-certified by the American College of Radiology Co-Medical Director of the Integrative Oncology and Wellness Center Member of the American Society for Therapeutic Radiology and Oncology Education: B.A. in Biology, Williams College (1983) Certificat de Merité, Cordon Bleu Académie Cuisine (1984) M.D., University of Maryland School of Medicine (1988) Residency in Radiation Oncology, Johns Hopkins Hospital (1989-1992) Research Interests: Dr. Ling specializes in advanced radiation treatment modalities, including stereotactic body radiotherapy and intensity modulated radiotherapy. Her work addresses breast cancer management, focusing on breast conserving therapy, reconstruction techniques, and mitigation of radiation therapy side effects such as bone loss, nausea, radiation dermatitis, and fatigue. She has contributed extensively to integrative approaches in oncology. Scientific Awards: Angel Award (2016) Jacob Gitelman Award (2016) Heart & Hands Award (2013) Rubin-Mitchell Teaching Award (2004) Publications Trends: Dr. Ling's research spans clinical trials (curcumin for radiation dermatitis), technical advancements (IMRT dosimetry), and integrative medicine applications in oncology. Her work emphasizes patient-centered outcomes, particularly in breast cancer survivorship and symptom management.

• Radiation Oncology
• Urologic Malignancies
• Prostate Cancer Treatment
• +۳ مورد دیگر

Joseph G. Cardinale, MD, is an Associate Clinical Professor of Therapeutic Radiology at Yale School of Medicine. He specializes in radiation oncology with over 30 years of expertise in treating urologic malignancies, particularly prostate cancer. His clinical practice emphasizes individualized patient care using advanced techniques like radiosurgery, brachytherapy, and IMRT. He leads a prostate cancer program at Yale Medicine and engages in outreach for medically underserved communities. His research focuses on minimizing organ removal in cancer treatment. Education: BS, Manhattan College (1976) MD, New York Medical College (1980) Residency in Therapeutic Radiology, Yale-New Haven Hospital (1984) Board Certifications: Therapeutic Radiology (AB of Radiology, 1984) Key Contributions: Developed a prostate cancer program at Yale Medicine; advocates for minimally invasive cancer therapies to preserve organ function. Conducts clinical research to improve treatment efficacy with reduced side effects. Contact: Based at Yale New Haven Hospital, reachable via joseph.cardinale@yale.edu or (203) 789-3131.

Wendla K. Citronمشاهده پروفایل

استادیار بالینی

• CNS malignancies
• Head and neck cancer
• Lung cancer
• +۱۱ مورد دیگر

Wendla K. Citron is a Clinical Assistant Professor in the Department of Radiation Oncology at the University of Maryland School of Medicine. She serves as Medical Director of the Tate Cancer Center at University of Maryland Baltimore Washington Medical Center and co-directs the Radiation Oncology Residency Program. Education: Bachelor of Science in Biology from MIT (1996), MD from Wake Forest University School of Medicine (2001). Training: Internship in Internal Medicine (2002), Residency in Radiation Oncology at the University of Chicago (2006). Dr. Citron specializes in treating diverse malignancies (CNS, breast, head/neck, lung, GI, GU, gynecologic, lymphoma, and sarcoma) with advanced radiation modalities including 3D Conformal Radiation Therapy , Proton Therapy , and Image Guided Radiation Therapy . Her research emphasizes breast cancer , radiation oncology innovations , and improving treatment outcomes for elderly patients. Her publications focus on breast cancer treatment protocols, radiation therapy efficacy, and health disparities in oncology. Dr. Citron's clinical expertise extends to breast conservation therapy, leveraging technical advances to minimize side effects and treatment inconvenience.